APA

Dungarwalla M., Marsh J. C. W., Tooze J. A., Lucas G., Ouwehand W., Pettengell R., Dearden C. E., Gordon Smith E. C. & Elebute M. O. (20071107). Lack of clinical efficacy of rituximab in the treatment of autoimmune neutropenia and pure red cell aplasia: implications for their pathophysiology. : Annals of hematology.

Chicago

Dungarwalla M, Marsh J C W, Tooze J A, Lucas G, Ouwehand W, Pettengell R, Dearden C E, Gordon Smith E C and Elebute M O. 20071107. Lack of clinical efficacy of rituximab in the treatment of autoimmune neutropenia and pure red cell aplasia: implications for their pathophysiology. : Annals of hematology.

Harvard

Dungarwalla M., Marsh J. C. W., Tooze J. A., Lucas G., Ouwehand W., Pettengell R., Dearden C. E., Gordon Smith E. C. and Elebute M. O. (20071107). Lack of clinical efficacy of rituximab in the treatment of autoimmune neutropenia and pure red cell aplasia: implications for their pathophysiology. : Annals of hematology.

MLA

Dungarwalla M, Marsh J C W, Tooze J A, Lucas G, Ouwehand W, Pettengell R, Dearden C E, Gordon Smith E C and Elebute M O. Lack of clinical efficacy of rituximab in the treatment of autoimmune neutropenia and pure red cell aplasia: implications for their pathophysiology. : Annals of hematology. 20071107.